Elanco Animal Health Inc (NYSE:ELAN) shares traded 1.00% higher at $14.08 on Wall Street last session.
ELAN stock price is now -5.57% away from the 50-day moving average and -3.20% away from the 200-day moving average. The market capitalization of the company currently stands at $6.96B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $13 to $20, Stifel Upgraded its rating from Hold to Buy for Elanco Animal Health Inc (NYSE: ELAN). On December 19, 2023, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $17, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, Simmons Jeffrey N, PRESIDENT, CEO AND DIRECTOR bought 100,000 shares of the company’s stock on Aug 12 ’24. The stock was bought for $1,300,610 at an average price of $13.01. Upon completion of the transaction, the PRESIDENT, CEO AND DIRECTOR now directly owns 145,000 shares in the company, valued at $2.04 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 21 ’24, Director DOYLE WILLIAM F bought 15,000 shares of the business’s stock. A total of $254,700 was incurred on buying the stock at an average price of $16.98. This leaves the insider owning 76,330 shares of the company worth $1.07 million. A total of 1.23% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $8.52 and a high of $18.80. As of last week, the company has a debt-to-equity ratio of 0.96, a current ratio of 2.93, and a quick ratio of 1.75. The fifty day moving average price for ELAN is $14.8376 and a two-hundred day moving average price translates $14.5734 for the stock.
The latest earnings results from Elanco Animal Health Inc (NYSE: ELAN) was released for 2024-06-30. The net profit margin was -27.94% and return on equity was -18.78% for ELAN. The company reported revenue of $1.18 billion for the quarter, compared to $1.06 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.02 percent. For the current quarter, analysts expect ELAN to generate $1.05B in revenue.
